These data suggest for a correlation between the protein levels of CIN85 and E3-inactivated CBL in facilitating breast cancer progression; hence, there might be therapeutic potential in disrupting the CBL–CIN85 interaction. The gene discussed is SH3KBP1; the disease is breast carcinoma.